References
Campanati A, Ganzetti G, Sario AD, Damiani A, Sandroni L, Rosa L, et al. The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. J Gastroenterol. 2012 Oct 13. doi:10.1007/s00535-012-0678-9.
Vaccaro O, Masulli M, Cuomo V, Rivellese AA, Uusitupa M, Vessby B, et al. Comparative evaluation of simple indices of insulin resistance. Metabolism. 2004;53(12):1522–6.
Kawada T. Preliminary report: homeostasis model assessment of insulin resistance, an indicator of insulin resistance, is strongly related to serum insulin: practical data presentation and the mathematical basis. Metabolism. 2010;59(7):1044–6.
Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–95.
Martinez-Hervas S, Argente C, Garcia-Jodar J, Priego A, Real JT, Carratala A, et al. Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a postprandial method based on oral glucose tolerance test. Metabolism. 2011;60(5):740–6.
Conflict of interest
There is no conflict of interest in this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
An answer to this letter to the editor is available at doi:10.1007/s00535-013-0769-2.
Rights and permissions
About this article
Cite this article
Kawada, T. Insulin-related biomarkers and their relationship with hepatic fibrosis risk in patients with psoriasis, metabolic syndrome and non-alcoholic fatty liver disease. J Gastroenterol 48, 671–672 (2013). https://doi.org/10.1007/s00535-013-0768-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-013-0768-3